Table 3 The value of CCAT2, CA125 and SCC in diagnosing primary CC
From: Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer
Molecular marker | Sensitivity | Specificity | Accuracy | Positive prediction | Negative prediction |
|---|---|---|---|---|---|
(%) | (%) | (%) | (%) | (%) | |
CCAT2 | 73.33 | 87.00 | 78.21 | 91.03 | 64.44 |
(132/180) | (87/100) | (219/280) | (132/145) | (87/135) | |
CA125 | 81.67 | 46.00 | 68.93 | 73.13 | 58.23 |
(147/180) | (46/100) | (193/280) | (147/201) | (46/79) | |
SCC | 69.44 | 90.00 | 76.79 | 92.59 | 62.07 |
(125/180) | (90/100) | (215/280) | (125/135) | (90/145) | |
CCAT2+CA125 | 91.67 | 89.00 | 90.71 | 93.75 | 85.58 |
(165/180) | (89/100) | (254/280) | (165/176) | (89/104) | |
CCAT2+SCC | 82.22 | 96.00 | 87.14 | 97.37 | 75.00 |
(148/180) | (96/100) | (244/280) | (148/152) | (96/128) | |
Three combination | 94.44 | 96.00 | 95.00 | 97.70 | 90.57 |
(170/180) | (96/100) | (266/280) | (170/174) | (96/106) |